Robinhood Markets, Inc.’s BriaCell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCTX
Robinhood Markets, Inc.'s BCTX Position: Q3 2026 in Review
Robinhood Markets, Inc. opened a new position in BriaCell Therapeutics (BCTX) in Q3 2026: 1 share worth $4. The stake represents ﹤0.01% of the portfolio and ranks #1366 among its holdings.
19 funds tracked by Wall St. Rank hold BCTX as of Q3 2026.
- Robinhood Markets, Inc. held 1 share of BriaCell Therapeutics worth $4 as of Q3 2026.
- BriaCell Therapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
- BriaCell Therapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1366 holding.
- 19 funds tracked by Wall St. Rank held BriaCell Therapeutics as of Q3 2026.
Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.